SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

ImmunoCellular Therapeutics, Ltd. (IMUC)

IMUC RSS Feed
Add IMUC Price Alert      Hide Sticky   Hide Intro
Moderator: makingbiigdough
Search This Board: 
Last Post: 12/16/2017 1:35:05 AM - Followers: 211 - Board type: Free - Posts Today: 3

 


 

 

ImmunoCellular Therapeutics continues to make significant progress in meeting important goals and positioning the company for success. We believe that our cancer vaccine platform has the potential to be transformative in the treatment of cancer, and to create value for all our stakeholders. Our goal is to build ImmunoCellular into a leading, independent commercial-stage cancer immunotherapy company.





Our dendritic cell (DC) vaccine technology and advanced manufacturing offer several advantages over earlier-generation cellular immunotherapies:

Potency
- Matured DCs secrete IL12, which is critical for stimulating T cell killing of cancer cells.
More than 80% of the final manufactured product consists of matured DCs.

Versatility
- Unlike other cell-based vaccines, our DCs target multiple antigens, thus increasing the likelihood of effective treatment.

Efficiency
- Advanced manufacturing enables production of at least 20 doses of vaccine from a single apheresis (blood collection); thus patients do not need to undergo additional apheresis procedures.

Cost-effectiveness
- Compared to the only approved cell-based immunotherapy, our DC vaccines can be manufactured at a significantly reduced cost.

Convenience
- Ability to freeze and store vaccine for months or years eliminates the need to administer to the patient shortly after manufacture.
- Intradermal administration route reduces the time and inconvenience of intravenous infusion for both patient and physician.


Company Information:

21900 Burbank, 3rd Floor
Woodland Hills, CA 91367

Phone: 818-992-2907

http://www.imuc.com 

-
Management:
  
http://imuc.com/team/

Technologies:   http://imuc.com/technology/

Press Releases:   http://imuc.com/press/

http://finance.yahoo.com/q/h?s=IMUC+Headlines
 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0000822411&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 -

Transfer Agent:

U.S. Stock Transfer Corp.
Suite 200
Glendale, CA 91204-2991

 Investor Relations:

Gary Nash, CEOcast, Inc.

Tel: (212)732-4300
Email: IR@imuc.com




 

 PIPELINE 







http://www.imuc.com/pipeline/ict-107/ict-107-faq

http://www.imuc.com/pipeline/ict-121

http://www.imuc.com/pipeline/ict-140



 UPDATE 



ImmunoCellular has concluded a phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. ImmunoCellular's pipeline also includes: ICT-121, a dendritic cell vaccine targeting CD133; ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells; and the Stem-to-T-cell research program which engineers the patient's hematopoietic stem cells to generate antigen-specific cancer killing T-cells.

Announced the establishment of an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM). This agreement with PharmaCell, a leading European contract manufacturing organization focuses on the production of human cell therapy products, and is designed to enable ImmunoCellular to access phase 3 supplies of ICT-107, manufactured with ImmunoCellular's commercial-ready production process. ImmunoCellular intends to initiate a Phase 3 registrational program for ICT-107 in the US and in Europe in 2015
.   


>>> What these CANCER vaccines could be worth
 

 NEW  


Investor Presentation -> http://files.shareholder.com/downloads/AMDA-1HS8HT/61684022x0x652321/5FD13B20-8F93-44CE-994E-D5515E5F30FC/IMI_Corporate_Overview.pdf 



 

 

 

 

SureTrader
Interactive Brokers Advertisement
IMUC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IMUC News: ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program 12/13/2017 04:05:00 PM
IMUC News: ImmuncoCellular Therapeutics to Present at the 10th Annual LD Micro Main Event on December 7, 2017 11/22/2017 06:00:00 AM
IMUC News: Current Report Filing (8-k) 11/21/2017 04:22:57 PM
IMUC News: Quarterly Report (10-q) 11/21/2017 04:06:01 PM
IMUC News: ImmunoCellular Therapeutics Announces Third Quarter 2017 Financial Results 11/21/2017 04:05:00 PM
PostSubject
#4976   -18% was to much knrorrel 12/16/17 01:35:04 AM
#4975   $IMUC HAS EASY TENBAGGER POTENTIAL IN THE NEXT WEEKS knrorrel 12/16/17 12:35:35 AM
#4974   AGREEMENT knrorrel 12/16/17 12:33:54 AM
#4973   An 80.2% survival rate as compared to 27% ToddM 12/15/17 07:50:14 PM
#4972   https://www.fiercepharma.com/special-report/ict-107-10-promising-therapeutic-vac no shorts 12/15/17 05:34:58 PM
#4971   * * $IMUC Video Chart 12-15-17 * * ClayTrader 12/15/17 05:34:08 PM
#4970   Wow. I dont see it on level 2 Ericj5592 12/15/17 05:14:14 PM
#4969   200000 bid now ! knrorrel 12/15/17 05:12:38 PM
#4968   I miss the time, where it ran after knrorrel 12/15/17 05:06:35 PM
#4967   IMUC buy 0.035 stocktrademan 12/15/17 05:01:13 PM
#4966   i bets not , that would be + knrorrel 12/15/17 05:00:51 PM
#4965   now -20% that is very very sad knrorrel 12/15/17 04:58:37 PM
#4964   Shorts will attack this if it opens premarket Ericj5592 12/15/17 04:30:19 PM
#4963   Careful this could disappoint like the supernova DCTH Ericj5592 12/15/17 04:12:34 PM
#4962   Averaged down and hoping for the best. Seems no shorts 12/15/17 04:10:34 PM
#4961   ASK NOW A/H '42 WEEEEEEEE knrorrel 12/15/17 04:05:15 PM
#4960   Picked up some more at .34 for that no shorts 12/15/17 03:56:04 PM
#4959   do it like dpw now - jump jump jump knrorrel 12/15/17 03:54:25 PM
#4958   $imuc = a / h should be exciting, knrorrel 12/15/17 03:49:32 PM
#4957   Hey did you notice the stock is in Ericj5592 12/15/17 03:38:03 PM
#4956   We will get passed it today imo declaes 12/15/17 03:19:59 PM
#4955   Thats the wall Ericj5592 12/15/17 03:18:37 PM
#4954   Let's break 0,36$ for a starter. declaes 12/15/17 03:11:49 PM
#4953   NEWS WAS GREAT // $1 NEXT WEEK BACK knrorrel 12/15/17 02:53:30 PM
#4952   Yeah it looks good at .3471 Ericj5592 12/15/17 02:43:46 PM
#4951   A/H greeeeen looks now very good knrorrel 12/15/17 02:42:45 PM
#4950   Power hour Ericj5592 12/15/17 02:30:41 PM
#4949   Hopefully there's some volume during power hour. It Ericj5592 12/15/17 02:18:27 PM
#4948   Bounced to .36 Ericj5592 12/15/17 02:10:30 PM
#4947   $IMUC BOUNCE NOW HARD TO GREEEEEN http://www.nasdaq.com/symbol/imuc/real-time knrorrel 12/15/17 01:20:46 PM
#4946   dip and loading after great news knrorrel 12/15/17 11:53:42 AM
#4945   Short squeeze here this will jump even higher Ericj5592 12/15/17 11:23:40 AM
#4944   Sounds like it. Guess will touch .29 before seftest 12/15/17 11:14:34 AM
#4943   Rough day here for those who bought into Uphill Battle 12/15/17 11:13:31 AM
#4942   Whats going on here? seftest 12/15/17 11:11:17 AM
#4941   This is rapidly setting up to be the UFO 12/15/17 11:08:31 AM
#4940   IMUC...3412...Getting close to the gap fill at 28 range... georgie18 12/15/17 10:48:26 AM
#4939   I added again at 0,341. Sold half yesterday declaes 12/15/17 10:17:18 AM
#4938   Support around .24 - .28 cbsstanley 12/15/17 10:10:16 AM
#4937   It should be green today!! Joecanada13 12/15/17 09:48:44 AM
#4936   Going green ! Come on IMUC ! no shorts 12/15/17 09:39:52 AM
#4935   Got it thanks. And makes sense how we no shorts 12/15/17 08:22:49 AM
#4934   They vary. For the July financing, I believe Ericj5592 12/15/17 08:18:59 AM
#4933   Wait I'll ask Ericj5592 12/15/17 07:44:37 AM
#4932   Any idea what the strike price is? no shorts 12/15/17 07:40:56 AM
#4931   Apparently the warrants created more shares in the Ericj5592 12/15/17 07:36:24 AM
#4930   A potential cure for cancer. Got to feel no shorts 12/15/17 07:29:18 AM
#4929   Currently more buying than selling on Level 2 Ericj5592 12/15/17 07:24:25 AM
#4928   Breakout ihub board stock Ericj5592 12/15/17 04:44:53 AM
#4927   $IMUC IS NOW #1 BB BOOOOOMING OVER DOLLAR COMES knrorrel 12/15/17 04:37:50 AM
PostSubject